In Vitro Challenge using Thymoquinone on Hepatocellular Carcinoma (HepG2) Cell Line

Sohair A. Hassan; Wafaa A. Ahmed; Fayek M. Galeb; Maha A. El-Taweel; Farid A. Abu-Bedair

doi:10.22037/ijpr.2010.777

IJ Pharmaceutical Research

Current Issue All Issues In Press Accepted Manuscripts

Journal Information Editors & Boards Indexing and Listing Sources Journal Metrics Open Peer Review (OPR)Publication Ethics and Malpractice Statement Reviewer and AE Registration Form Support Contact Us

APC

Authors Guide Submit Manuscript

https://doi.org/10.22037/ijpr.2010.777

In Vitro Challenge using Thymoquinone on Hepatocellular Carcinoma (HepG2) Cell Line

Author(s):

Sohair A. Hassan^1,*,

Wafaa A. Ahmed²,

Fayek M. Galeb³,

Maha A. El-Taweel⁴,

Farid A. Abu-Bedair¹

1Department of Medicinal Chemistry, National Research Centre, Dokki, Giza, Egypt

2Department of Cancer Biology, NCI, Cairo University, Cairo, Egypt

3Department of Clinical Pathology Research Institute of Ophthalmology, Cairo University, Cairo, Egypt

4Department of Clinical Pathology, NCI, Cairo University, Cairo, Egypt

IJ Pharmaceutical Research:Vol. 7, issue 4; 283-290

Published online:Nov 20, 2010

Article type:Research Article

Received:Dec 01, 2007

Accepted:Aug 01, 2008

How to Cite:Hassan SA, Ahmed WA, Galeb FM, El-Taweel MA, Abu-Bedair FA. In Vitro Challenge using Thymoquinone on Hepatocellular Carcinoma (HepG2) Cell Line. Iran J Pharm Res. 2022;7(4):e128603. doi: https://doi.org/10.22037/ijpr.2010.777

Abstract

Black seed (Nigella sativa) is considered as a biological response modifier. Thymoquinone (TQ) is the bioactive and the most abundant constituent of the volatile oil of this seed which has been shown to possess anti-inflammatory, antioxidant and anti-neoplastic effects. In this study, the effect of TQ on HepG2 cell line was investigated in an attempt to identify its potential mechanism of action. Cell viability and proliferation were assessed in presence of different concentrations of TQ, which revealed a remarkable inhibition of HepG2 cells by TQ in a dose dependant manner. TQ ability to induced apoptosis was determined by Flowcytometry and colorimetric measurement of Caspases 3 and 9. The apoptotic effect of TQ was much more dramatic after 12 h treatment and the activity of Caspases 3 and 9 was increased. Also, Flowcytometric analysis of cell cycle revealed an early G₁/S arrest of cells, which is characteristic of apoptosis. It could be concluded that Thymoquinone is a promising anti-cancer agent for hepatocellular carcinoma.

Keywords

Import into EndNote Import into BibTex

Crossmark

Checking

Share on

Comments

Number of Comments:0

Cited by

Scopus by DOI: 0
Last Update: 4 days ago
Scopus by Title: 26
Last Update: 4 days ago
Scopus by Title (Ref): 0
Last Update: 4 days ago
CrossRef: 2
Last Update: 2 days ago

Metrics

Get Permission (article level)

Ordering Reprints

Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC

Search Relations

Author(s):

Sohair A. Hassan:[PubMed][Scholar]
Wafaa A. Ahmed:[PubMed][Scholar]
Fayek M. Galeb:[PubMed][Scholar]
Maha A. El-Taweel:[PubMed][Scholar]
Farid A. Abu-Bedair:[PubMed][Scholar]

Outlines

In Vitro Challenge using Thymoquinone on Hepatocellular Carcinoma (HepG2) Cell Line

Abstract

Crossmark

Checking

Last Update: 4 days ago

Last Update: 4 days ago

Last Update: 4 days ago

Last Update: 2 days ago